Source: Clinical Chemistry. Conference titles: AACC Annual Meeting. Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, CITOCROMO P-450
ABNT
HIRATA, Rosario Dominguez Crespo et al. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 set. 2024. , 2006APA
Hirata, R. D. C., Willrich, M. A. V., Dorea, E. L., Bernik, M. M. S., Bertolami, M. C., Faludi, A. A., et al. (2006). Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Hirata RDC, Willrich MAV, Dorea EL, Bernik MMS, Bertolami MC, Faludi AA, Rebecchi IMM, Sorkin SC, Dalla-Vecchia F, Rodrigues AC, Basques HH, Oliveira VS de, Hirata MH. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. 2006 ; 52( 6): A54-A55 res. B-52.[citado 2024 set. 10 ]Vancouver
Hirata RDC, Willrich MAV, Dorea EL, Bernik MMS, Bertolami MC, Faludi AA, Rebecchi IMM, Sorkin SC, Dalla-Vecchia F, Rodrigues AC, Basques HH, Oliveira VS de, Hirata MH. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. 2006 ; 52( 6): A54-A55 res. B-52.[citado 2024 set. 10 ]